Erythromycin in pityriasis rosea: A double-blind, placebo-controlled clinical trial

被引:77
|
作者
Sharma, PK
Yadav, TP
Gautam, RK
Taneja, N
Satyanarayana, L
机构
[1] Dr Ram Manohar Lohia Hosp, Dept Dermatol, Faizabad, India
[2] Dr Ram Manohar Lohia Hosp, Dept Pediat, Faizabad, India
[3] Lady Hardinge Med Coll, Dept Microbiol, New Delhi, India
[4] Inst Cytol & Prevent Oncol, New Delhi, India
关键词
D O I
10.1016/S0190-9622(00)90132-4
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: The study stemmed from an incidental observation of improvement in 2 patients with pityriasis rosea while receiving erythromycin. Objective: The purpose of the study was to evaluate the efficacy of erythromycin in patients with pityriasis rosea. Methods: A double-blind, placebo-controlled clinical study was performed in an outpatient setting in a major hospital. Ninety patients over a period of years were alternatively assigned to treatment group or placebo group. Patients in the treatment group received erythromycin in divided doses for 14 days. The response was categorized as complete response, partial response, or no response. All patients were followed up for 6 weeks. Results: Both groups were comparable with regard to age at presentation, sex, and average duration of disease at the time of reporting to the clinic. Upper respiratory tract infection before the appearance of skin lesions was reported in 68.8% of all patients. Complete response was observed in 33 patients (73.33%) in the treatment group and none in the placebo group (P < .0001). Conclusion: Oral erythromycin was effective in treating patients with pityriasis rosea.
引用
收藏
页码:241 / 244
页数:4
相关论文
共 50 条
  • [1] The efficacy of azithromycin in pityriasis rosea: A randomized, double-blind, placebo-controlled trial
    Pandhi, Deepika
    Singal, Archana
    Verma, Prashant
    Sharma, Reena
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2014, 80 (01): : 36 - 40
  • [2] Author's Response - The efficacy of azithromycin in pityriasis rosea: A randomized, double-blind, placebo-controlled trial
    Pandhi, Deepika
    Verma, Prashant
    Singal, Archana
    Sharma, Reena
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2015, 81 (01):
  • [3] DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF ERYTHROMYCIN IN THE TREATMENT OF CLINICAL CAMPYLOBACTER INFECTION
    MANDAL, BK
    ELLIS, ME
    DUNBAR, EM
    WHALE, K
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 13 (06) : 619 - 623
  • [5] A PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL OF ERYTHROMYCIN IN ADULTS WITH ACUTE BRONCHITIS
    DUNLAY, J
    REINHARDT, R
    ROI, LD
    JOURNAL OF FAMILY PRACTICE, 1987, 25 (02): : 137 - 141
  • [6] The cult of the double-blind placebo-controlled trial
    Ellis, SJ
    Adams, RF
    BRITISH JOURNAL OF CLINICAL PRACTICE, 1997, 51 (01): : 36 - 39
  • [7] Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial
    Maggie C Walter
    Peter Reilich
    Simone Thiele
    Joachim Schessl
    Herbert Schreiber
    Karlheinz Reiners
    Wolfram Kress
    Clemens Müller-Reible
    Matthias Vorgerd
    Peter Urban
    Bertold Schrank
    Marcus Deschauer
    Beate Schlotter-Weigel
    Ralf Kohnen
    Hanns Lochmüller
    Orphanet Journal of Rare Diseases, 8
  • [8] Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial
    Walter, Maggie C.
    Reilich, Peter
    Thiele, Simone
    Schessl, Joachim
    Schreiber, Herbert
    Reiners, Karlheinz
    Kress, Wolfram
    Mueller-Reible, Clemens
    Vorgerd, Matthias
    Urban, Peter
    Schrank, Bertold
    Deschauer, Marcus
    Schlotter-Weigel, Beate
    Kohnen, Ralf
    Lochmueller, Hanns
    ORPHANET JOURNAL OF RARE DISEASES, 2013, 8
  • [9] CERVICOVAGINAL MICROFLORA AND PREGNANCY OUTCOME - RESULTS OF A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ERYTHROMYCIN TREATMENT
    MCGREGOR, JA
    FRENCH, JI
    RICHTER, R
    VUCHETICH, M
    BACHUS, V
    SEO, K
    HILLIER, S
    JUDSON, FN
    MCFEE, J
    SCHOONMAKER, J
    TODD, JK
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (05) : 1580 - 1591
  • [10] Acyclovir is not effective in pityriasis rosea: Results of a randomized, triple-blind, placebo-controlled trial
    Singh, Sanjay
    Anurag
    Tiwary, Narendra K.
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2016, 82 (05): : 505 - 509